Back

Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction

30 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Epidemiology and risk factors in cardiovascular disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Akihiro Takasaki

Mie University Hospital, Tsu (Japan)

7 More presentations in this session

Presentation thumbnail
Ethnic variations in post ST elevation myocardial infarction inflammatory kinetics
Doctor M. Sadler (London, GB)
Abstract Slides Video
Presentation thumbnail
ChineseCVD: a web-based Chinese-specifi c cardiovascular risk calculator incorporating long COVID, COVID-19vaccination, SGLT2i and PCSK9i treatment effects
Professor G. Tse (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Which is better for predicting and discriminating cardiovascular events: a traditional risk score, a calcium score or a genetic risk score?
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences in clinical characteristics, phenotypes, management, and long-term outcomes of myocardial injury: an international cohort study
Mr C. Spagnuolo (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Age stratified differences in coronary artery plaque phenotype in women and men with non-obstructive coronary artery disease
Doctor C. Berge Hondros (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and risk factors in cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: findings from the FRENCHIE cohort.
thumbnail
Congress Presentation
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
thumbnail
Congress Presentation
Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources